All Releases
View Summary Celldex Announces Upcoming Presentation at the Deutsche Bank 2013 BioFEST
Nov 27, 2013
PDF 14.9 KB Add to Briefcase
View Summary Celldex Therapeutics' Rindopepimut Demonstrates Promising Clinical Activity in Patients with EGFRvIII-positive Recurrent Glioblastoma at SNO
Nov 24, 2013
PDF 32.6 KB Add to Briefcase
View Summary Celldex Therapeutics Announces Publication of Preliminary Data from the Phase 2 ReACT Study to be Presented at the 18th Annual Scientific Meeting of the Society for Neuro-Oncology (SNO)
Nov 11, 2013
PDF 20.6 KB Add to Briefcase
View Summary Celldex Reports Third Quarter 2013 Financial Results
Nov 8, 2013
PDF 28.9 KB Add to Briefcase
View Summary Celldex Therapeutics' CDX-1127 Well Tolerated and Demonstrates Anti-Tumor Activity in Phase 1 Dose-Escalation Study
Nov 7, 2013
PDF 25.7 KB Add to Briefcase
View Summary Celldex Therapeutics Announces Upcoming Data Presentations at the Society for Immunotherapy of Cancer and Society of Neuro-Oncology Annual Meetings
Oct 21, 2013
PDF 17.5 KB Add to Briefcase
View Summary Celldex Therapeutics Announces Upcoming Presentation at the Leerink Swann Rare Disease Roundtable
Sep 26, 2013
PDF 15.1 KB Add to Briefcase
View Summary Celldex Announces Expansion of Phase 2 ReACT Study in Recurrent Glioblastoma
Aug 12, 2013
PDF 21.2 KB Add to Briefcase
View Summary Celldex Reports Second Quarter 2013 Financial Results
Aug 6, 2013
PDF 28.8 KB Add to Briefcase
View Summary Celldex Therapeutics Announces Issuance of Seminal Patent for CD27 Agonists
Jul 10, 2013
PDF 20.2 KB Add to Briefcase
View Summary Celldex Therapeutics Initiates Pilot Study in Dense Deposit Disease
Jul 1, 2013
PDF 61.6 KB Add to Briefcase
View Summary Celldex Therapeutics to Present at Two Upcoming Investor Conferences
May 22, 2013
PDF 14.8 KB Add to Briefcase
View Summary Celldex Therapeutics Announces Upcoming Presentation at the Credit Suisse 2013 Antibody Day
May 6, 2013
PDF 14.7 KB Add to Briefcase
View Summary Celldex Reports First Quarter 2013 Financial Results
May 2, 2013
PDF 28.3 KB Add to Briefcase
View Summary Celldex Presents CDX-1127 In Vitro Human Data Consistent With Strong Potency and Safety Profile at AACR 2013
Apr 8, 2013
PDF 56.8 KB Add to Briefcase
View Summary Celldex Reports Fourth Quarter and Fiscal 2012 Financial Results
Mar 7, 2013
PDF 32.5 KB Add to Briefcase
View Summary Celldex Therapeutics to Report Fourth Quarter and Fiscal 2012 Financial Results and Host Corporate 2013 Strategic Outlook Call
Feb 28, 2013
PDF 15.3 KB Add to Briefcase
View Summary Positive Data From Celldex's Phase 1 Study of CDX-301 Support Initiation of Pilot Study in Hematopoietic Stem Cell Transplantation
Feb 14, 2013
PDF 19.1 KB Add to Briefcase
View Summary Celldex Therapeutics Announces Upcoming Presentation at Leerink Swann Global Healthcare Conference 2013
Feb 11, 2013
PDF 14.5 KB Add to Briefcase
View Summary Celldex Announces Upcoming Oral Presentation on CDX-301 at the American Society for Blood and Marrow Transplantation 2013 BMT Tandem Meetings
Feb 11, 2013
PDF 17.9 KB Add to Briefcase
Showing 101-120 of 153 Page: 1 2 3 4 5 6 7 8  Previous 20 | Next 20
Showing 101-120 of 153
Page: 1 2 3 4 5 6 7 8
 Previous 20 | Next 20
Add to Briefcase = add release to Briefcase